These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1059498)

  • 1. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.
    Evans DI; Jones PH; Morley CJ
    Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged remission maintenance in acute myeloid leukaemia.
    Spiers AS; Goldman JM; Catovsky D; Costello C; Galton DA; Pitcher CS
    Br Med J; 1977 Aug; 2(6086):544-7. PubMed ID: 268229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
    Uzuka Y; Liong SK; Yamagata S
    Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Haematol; 1974 Jul; 27(3):373-89. PubMed ID: 4607313
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 8. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High remission-induction rate in acute myeloid leukaemia.
    Gale RP; Cline MJ
    Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia.
    Eppinger-Helft M; Pavlovsky S; Suarez A; Muriel FS; Hidalgo G; Pavlovsky A; Vilaseca G
    Cancer; 1975 Feb; 35(2):347-53. PubMed ID: 1053936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.
    Wiernik PH; Glidewell OJ; Hoagland HC; Brunner KW; Spurr CL; Cuttner J; Silver RT; Carey RW; DelDuca V; Kung FH; Holland JF
    Med Pediatr Oncol; 1979; 6(3):261-77. PubMed ID: 381887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our experience in the treatment of acute myeloblastic leukemia].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL; Cordero di Montezemolo L
    Minerva Pediatr; 1974 Nov; 26(34):1744-7. PubMed ID: 4530152
    [No Abstract]   [Full Text] [Related]  

  • 18. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.
    Rees JK; Sandler RM; Challener J; Hayhoe FG
    Br J Cancer; 1977 Dec; 36(6):770-6. PubMed ID: 271512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative observations in the treatment of acute leukaemia.
    Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
    Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.